Revvity | PKI - 税前利润

股票价格
88.94
每天变化
1.02 1.16%
每月一次
-7.31%
每年
-11.72%
Q2 预测
81.38


金融业
股票价格
USD
资产
USD 12.17B
现金及等价物
USD 919.86M
销售成本
USD 350.4M
流动资产
USD 2.24B
流动负债
USD 1.33B
债务
USD 3.37B
股息收益率
0.29
EBIT
USD 145.83M
EBITDA
USD 248.91M
员工
11K
EPS每股收益
USD 1.7
股本和储备
USD 7.38B
销售毛利
USD 421.66M
债务利息支出
USD 23.51M
利息收入
USD 0.4
贷款资金
USD 2.63B
市值
USD 10.99B
净收入
USD 98.36M
营业费用
USD 626.22M
营业利润
USD 145.83M
普通股股本
USD 113.38M
PE价格收益
49.87
税前利润
USD 55.68M
销售收入
USD 772.06M
销售和管理费用
USD 251.73M
股票
USD 379.5M
贸易债权人
USD 185.46M
应收帐款人
USD 744.67M


税前利润 更改 日
Agilent USD 442M 1000K 2025-09
Align Technology USD 176.6M 81.86M 2025-12
Bio Techne USD 84.99M 107.85M 2025-09
Bio-Rad Laboratories USD 82.9M 331.1M 2025-09
Bruker USD -72.6M 73.1M 2025-09
Celltrion KRW 14.6B 180.89B 2025-06
Charles River Laboratories USD 170.03M 98.62M 2025-09
Cspc Pharmaceutical CNY 505.59M 706M 2025-12
Danaher USD 1.08B 421M 2025-09
Dentsply International USD -230M 77M 2025-09
Dianthus Therapeutics USD -64.43M 27.67M 2025-12
Divis Laboratories Ltd INR 8.54B 580M 2025-12
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Hologic USD 229.7M 2.3M 2025-12
Illumina USD 220M 86M 2025-09
Intuitive Surgical USD 855.2M 23.1M 2025-09
IQVIA Holdings USD 6.16B 5.84B 2025-09
Kangmei Pharma CNY 2.07M 13.77M 2025-09
Knight Therapeutics CAD -1.92M 13.69M 2025-09
Laboratorios Farma EUR 26.78M 94.77M 2025-06
Laboratory Of America USD 337M 32.3M 2025-09
Medical Developments International AUD -149K 466K 2025-06
Mesa Laboratories USD -2.22M 6.03M 2024-12
Mettler Toledo International USD 269.24M 20.58M 2025-09
Myriad Genetics USD 4.6M 3.4M 2025-12
Neuren Pharmaceuticals AUD 9.86M 161.24M 2025-06
OraSure Technologies USD -18.43M 5.14M 2025-12
Organigram Holdings CAD -41.72M 25.52M 2025-09
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Pharma Mar EUR 40.2M 44.28M 2025-12
Qiagen NV USD 134.73M 7.91M 2025-09
Quest Diagnostics USD 336M 57M 2025-09
Quidel USD -756.9M 527.3M 2025-09
Repligen USD 17.11M 10.25M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Sartorius EUR 85M 14.1M 2025-09
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Tilray USD -39.96M 39.19M 2025-09
Waters USD 170.12M 7.57M 2025-09
Zealand Pharma A/S -406.5M 39.77M 2025-12
Zz Pientze Pharmaceu CNY 523.11M 659.54M 2025-06